Skip to main content
< Back to news
Genesis Biomed team - © Genesis Biomed

Genesis Biomed presents its new Genesis Ventures fund

Today Genesis Biomed has presented at the Barcelona Science Park a new investment fund, Genesis Ventures, made up of various family offices that are looking to invest in research and business projects in the very early stages in the field of biomedicine. With this initiative, the company based at PCB, wants to help entrepreneurs put together the capital they need for their research in order to later attract series-A corporate funds or venture capital.


The event has been held at the Barcelona Science Park, as part of its annual meeting and with more than one hundred researchers and entrepreneurs from the sector and representatives from benchmark associations.

The investment platform Genesis Ventures is envisaged as a very early-stage tool to help the development of excellent scientific projects to reach key value milestones to attract a first round of investment from venture or corporate funds.

“We’re an atypical funding vehicle and the only one of our kind in Spain. We’ll go out and do the science investors and regulatory agencies want, with the clear goal of developing innovative products”, say Josep Lluís Falcó, founder and CEO of Genesis Biomed, the company in charge of the management of the fund.

The new fund is sized in 610.000 € and will invest in projects or start-ups with 50.000 to 100.000 € tickets depending on the identified development needs. The investment period of the vehicle will finish in October 2019.